AstraZeneca is a multinational pharmaceutical company headquartered in Cambridge, United States. It was formed in 1999 through the merger of Astra AB, a Swedish pharmaceutical company, and Zeneca Group, a British pharmaceutical company. The company's headquarters in the United States is located in Cambridge, Massachusetts.

This location serves as the company's global research and development center, focusing on the discovery, development, and commercialization of innovative medicines. It is also home to AstraZeneca's executive leadership team. AstraZeneca offers a broad range of pharmaceutical products and services.

Its main therapeutic areas include cardiovascular, respiratory, oncology, and immunology, among others. The company's portfolio includes both prescription and over-the-counter medications, as well as biologics and vaccines. AstraZeneca is committed to improving patient outcomes and addressing unmet medical needs through its innovative medicines.

On a global scale, AstraZeneca operates in over 100 countries. The company has a significant presence in North America, Europe, and emerging markets worldwide. AstraZeneca has established several noteworthy subsidiaries and joint ventures, including MedImmune, a biologics research and development company, and partnerships with academic institutions and research centers.

AstraZeneca is one of the largest pharmaceutical companies globally and is well-known for its strong market position. In terms of global sales, the company consistently ranks among the top pharmaceutical companies. AstraZeneca faces competition from other major pharmaceutical companies in various therapeutic areas.

In recent years, AstraZeneca has made significant strides in its growth and innovation. It has achieved several milestones, such as the launch of innovative medicines and collaborations to advance research and development in key therapeutic areas. The company has also made strategic acquisitions and divestments to focus its portfolio and strengthen its pipeline.

As of the latest available information, AstraZeneca continues to drive scientific advancements and deliver value to patients and healthcare systems worldwide. The company remains committed to its mission of pushing the boundaries of science to deliver life-changing medicines